SAN DIEGO, July 21, 2026 (GLOBE NEWSWIRE)-- Axiom Biosciences, a clinical-stage biotechnology company whose lead regenerative therapy produced positive early results in newborns with severe brain ...
When recombinant DNA expert Herbert Boyer, Ph.D., first got a call from venture capitalist Robert Swanson about starting a ...
ARLINGTON, Mass., March 11, 2026 (GLOBE NEWSWIRE) -- KALA BIO, Inc. (NASDAQ: KALA) announces that it is ready to ship its first commercial AI product in approximately 14 days, transforming the Company ...